Erlotinib, an EGF receptor inhibitor that can reduce liver fibrosis and the development of hepatocellular carcinoma, suppressed the increased expression of Emp1 in GSE27640 (Figure 3(b)). The gene discussed is EMP1; the disease is Hepatic fibrosis.